Cardiotoxicidad inducida por tratamientos oncológicos. Fundamentos para la implementación de equipos de Cardio-Oncología
Recently, we have witnessed major improvements in cancer treatment. Early diagnosis and development of new therapies have reduced cancer-related mortality. However, these new therapies, along with greater patient survival, are associated with an increase in untoward effects, particularly in the card...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2018
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018000100068 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872018000100068 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720180001000682018-05-11Cardiotoxicidad inducida por tratamientos oncológicos. Fundamentos para la implementación de equipos de Cardio-OncologíaHameau,RenéGabrielli,LuigiGarrido,MarceloGuzmán,Ana MaríaRetamal,IgnacioVacarezza,María JoséGreig,DouglasOcqueteau,MauricioSánchez,CésarPizarro,MarcelaCorvalán,AlejandroLavandero,SergioCastro,Pablo F.Martínez,Gonzalo Cardiotoxicity Drug Therapy Heart Failure Cancer Radiotherapy Recently, we have witnessed major improvements in cancer treatment. Early diagnosis and development of new therapies have reduced cancer-related mortality. However, these new therapies, along with greater patient survival, are associated with an increase in untoward effects, particularly in the cardiovascular system. Although cardiotoxicity induced by oncologic treatments affects predominantly the myocardium, it can also involve other structures of the cardiovascular system, becoming one of the main causes of morbidity and mortality in those who survive cancer. The main objective of cardio-oncology is to achieve the maximum benefits of oncologic treatments while minimizing their deleterious cardiovascular effects. It harbors the stratification of patients at risk of cardiotoxicity, the implementation of diagnostic tools (imaging techniques and biomarkers) for early diagnosis, preventive strategies and early treatment options for the complications. Herein, we discuss the basic knowledge for the implementation of cardio-oncology units and their role in the management of cancer patients, the diagnostic tools available to detect cardiotoxicity and the present therapeutic options.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.146 n.1 20182018-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018000100068es10.4067/s0034-98872018000100068 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Cardiotoxicity Drug Therapy Heart Failure Cancer Radiotherapy |
spellingShingle |
Cardiotoxicity Drug Therapy Heart Failure Cancer Radiotherapy Hameau,René Gabrielli,Luigi Garrido,Marcelo Guzmán,Ana María Retamal,Ignacio Vacarezza,María José Greig,Douglas Ocqueteau,Mauricio Sánchez,César Pizarro,Marcela Corvalán,Alejandro Lavandero,Sergio Castro,Pablo F. Martínez,Gonzalo Cardiotoxicidad inducida por tratamientos oncológicos. Fundamentos para la implementación de equipos de Cardio-Oncología |
description |
Recently, we have witnessed major improvements in cancer treatment. Early diagnosis and development of new therapies have reduced cancer-related mortality. However, these new therapies, along with greater patient survival, are associated with an increase in untoward effects, particularly in the cardiovascular system. Although cardiotoxicity induced by oncologic treatments affects predominantly the myocardium, it can also involve other structures of the cardiovascular system, becoming one of the main causes of morbidity and mortality in those who survive cancer. The main objective of cardio-oncology is to achieve the maximum benefits of oncologic treatments while minimizing their deleterious cardiovascular effects. It harbors the stratification of patients at risk of cardiotoxicity, the implementation of diagnostic tools (imaging techniques and biomarkers) for early diagnosis, preventive strategies and early treatment options for the complications. Herein, we discuss the basic knowledge for the implementation of cardio-oncology units and their role in the management of cancer patients, the diagnostic tools available to detect cardiotoxicity and the present therapeutic options. |
author |
Hameau,René Gabrielli,Luigi Garrido,Marcelo Guzmán,Ana María Retamal,Ignacio Vacarezza,María José Greig,Douglas Ocqueteau,Mauricio Sánchez,César Pizarro,Marcela Corvalán,Alejandro Lavandero,Sergio Castro,Pablo F. Martínez,Gonzalo |
author_facet |
Hameau,René Gabrielli,Luigi Garrido,Marcelo Guzmán,Ana María Retamal,Ignacio Vacarezza,María José Greig,Douglas Ocqueteau,Mauricio Sánchez,César Pizarro,Marcela Corvalán,Alejandro Lavandero,Sergio Castro,Pablo F. Martínez,Gonzalo |
author_sort |
Hameau,René |
title |
Cardiotoxicidad inducida por tratamientos oncológicos. Fundamentos para la implementación de equipos de Cardio-Oncología |
title_short |
Cardiotoxicidad inducida por tratamientos oncológicos. Fundamentos para la implementación de equipos de Cardio-Oncología |
title_full |
Cardiotoxicidad inducida por tratamientos oncológicos. Fundamentos para la implementación de equipos de Cardio-Oncología |
title_fullStr |
Cardiotoxicidad inducida por tratamientos oncológicos. Fundamentos para la implementación de equipos de Cardio-Oncología |
title_full_unstemmed |
Cardiotoxicidad inducida por tratamientos oncológicos. Fundamentos para la implementación de equipos de Cardio-Oncología |
title_sort |
cardiotoxicidad inducida por tratamientos oncológicos. fundamentos para la implementación de equipos de cardio-oncología |
publisher |
Sociedad Médica de Santiago |
publishDate |
2018 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018000100068 |
work_keys_str_mv |
AT hameaurene cardiotoxicidadinducidaportratamientosoncologicosfundamentosparalaimplementaciondeequiposdecardiooncologia AT gabrielliluigi cardiotoxicidadinducidaportratamientosoncologicosfundamentosparalaimplementaciondeequiposdecardiooncologia AT garridomarcelo cardiotoxicidadinducidaportratamientosoncologicosfundamentosparalaimplementaciondeequiposdecardiooncologia AT guzmananamaria cardiotoxicidadinducidaportratamientosoncologicosfundamentosparalaimplementaciondeequiposdecardiooncologia AT retamalignacio cardiotoxicidadinducidaportratamientosoncologicosfundamentosparalaimplementaciondeequiposdecardiooncologia AT vacarezzamariajose cardiotoxicidadinducidaportratamientosoncologicosfundamentosparalaimplementaciondeequiposdecardiooncologia AT greigdouglas cardiotoxicidadinducidaportratamientosoncologicosfundamentosparalaimplementaciondeequiposdecardiooncologia AT ocqueteaumauricio cardiotoxicidadinducidaportratamientosoncologicosfundamentosparalaimplementaciondeequiposdecardiooncologia AT sanchezcesar cardiotoxicidadinducidaportratamientosoncologicosfundamentosparalaimplementaciondeequiposdecardiooncologia AT pizarromarcela cardiotoxicidadinducidaportratamientosoncologicosfundamentosparalaimplementaciondeequiposdecardiooncologia AT corvalanalejandro cardiotoxicidadinducidaportratamientosoncologicosfundamentosparalaimplementaciondeequiposdecardiooncologia AT lavanderosergio cardiotoxicidadinducidaportratamientosoncologicosfundamentosparalaimplementaciondeequiposdecardiooncologia AT castropablof cardiotoxicidadinducidaportratamientosoncologicosfundamentosparalaimplementaciondeequiposdecardiooncologia AT martinezgonzalo cardiotoxicidadinducidaportratamientosoncologicosfundamentosparalaimplementaciondeequiposdecardiooncologia |
_version_ |
1718436985878609920 |